28.1 C
Kuala Lumpur, MY
Tuesday, August 15, 2017

Tokyo Institute of Technology and Kawasaki City are Combining Forces in R&D on Computational Drug Discovery for Middle Molecules at Kawasaki KING SKYFRONT

TOKYO, Aug. 4, 2017 /PRNewswire/ -- On July 31, Tokyo Institute of Technology (Tokyo Tech) and Kawasaki City announced that they are combining forces to conduct R&D, construct an infrastructure, and implement a business promotion program for the "Program to Industrialize an Innovative Middle...

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

- Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR - Related patent application recently awarded in Australia; similar patents pending in other countries, favourable outcomes anticipated DARMSTADT, Germany, Aug. 3, 2017 /PRNewswire/ -- Merck, a leading science and...

Frost & Sullivan Acclaims Shimadzu for Delivering a Product Line of Versatile and Innovative Radiography Solutions

Shimadzu's products utilize advanced robotic capabilities and next-generation digital imaging technologies LONDON, Aug. 3, 2017 /PRNewswire/ -- Based on its recent analysis of the general radiography market, Frost & Sullivan recognizes Shimadzu Corporation with the 2017 Global Frost & Sullivan Award for Product Line Strategy Leadership....

A Delegation led by Director Li Weimin of West China Hospital, Sichuan University Visited the UK

CHENGDU, China, Aug. 2, 2017 /PRNewswire/ -- On July 9-14 this year, a delegation led by director Li Weimin of West China Hospital, Sichuan University visited University of Liverpool, Cambridge University Hospitals, and Imperial College London in the UK. The delegation consisted of representatives...

Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®

By controlling dangerous inflammation, CytoSorb® is enabling superior outcomes in critically-ill patients, with reduced overall costs of intensive care in its sights LONDON, Aug. 2, 2017 /PRNewswire/ -- Based on its recent analysis of the blood purification market, Frost & Sullivan recognizes CytoSorbents Corporation with the...

Frost & Sullivan Commends Credence ID’s Rollout of CredenceTAB(TM), a Biometric Tool that Combines Document Reading and Biometric Enrollment and Verification in a Portable Device

Credence ID's unique product suite offers convenience, portability, and customization to satisfy a wide range of identification projects SANTA CLARA, California, Aug. 1, 2017 /PRNewswire/ -- Based on its recent analysis of the mobile biometrics and credential reading market, Frost & Sullivan announced today the recognition...

Verdezyne Groundbreaking Ceremony in Malaysia Commemorates Initiation Of The World’s First Biobased DDDA Plant

-VerdePalm Plant to Use Sustainable Palm-based Materials to Manufacture Components of FerroShield™ Dibasic Acid Mixture for Superior Corrosion Inhibition CARLSBAD, Calif. and KUALA LUMPUR, Malaysia, July 31, 2017 /PRNewswire/ -- Verdezyne Inc., a synthetic biology company producing biobased chemicals, announced today that a groundbreaking ceremony was held on...

Redleaf Forming a “miniature United Nations”

SHANGHAI, July 28, 2017 /PRNewswire/ -- Shanghai Redleaf International Women's and Children's Hospital launched their fourth anniversary celebrations with a ceremony at 11am Sunday in the main lobby of the hospital. Redleaf babies of various nationalities came together to celebrate the birthday of those...

OrthoAccel Technologies, Inc. Names Orthodontic and Dental Industry Executive David Josza as CEO

HOUSTON, July 26, 2017 /PRNewswire/ -- OrthoAccel® Technologies, Inc. announces that its board of directors has named David Josza, an orthodontic and dental industry senior executive with more than 25 years of experience, as CEO effective August 1, 2017. A privately owned medical technology start-up, OrthoAccel...

Frost & Sullivan Acclaims CGI’s Advanced Genomic & Biomarker Technologies That Drive Industry Innovation in Support of Precision Cancer Treatment

CGI's technologies provide valuable insights across cancer diagnostics through the accurate and sensitive quantitation of clinically relevant genomic signatures & biomarkers from both blood and tissue samples SANTA CLARA, California, July 26, 2017 /PRNewswire/ -- Based on its recent analysis of the precision oncology industry, Frost...